Form 4: NRC Health Director Receives Equity Award

NRC Health Director Parul Bhandari was granted restricted stock units valued at $150,000, vesting in 2027.

Summary

• Director Parul Bhandari received an equity award on June 23, 2026.
• The award consists of restricted stock units (RSUs) with a value of $150,000.
• The number of RSUs granted was determined by dividing $150,000 by the closing stock price on the day before the Issuer's 2026 annual meeting.
• These RSUs are part of the Issuer's 2025 Omnibus Incentive Plan.
• The award is subject to vesting, forfeiture, and termination provisions.
• The RSUs will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director equity award and does not contain significant financial performance updates or strategic shifts.

Positives

• Director receives a significant equity award ($150,000) as part of the company's incentive plan.
• The equity award is structured to align the director's interests with long-term shareholder value, with vesting occurring in 2027.

Risks

• The value of the RSUs is dependent on the company's stock price, which can fluctuate.
• Vesting is subject to forfeiture and termination provisions, meaning the director could lose the award under certain circumstances.

Future Outlook

The restricted stock units granted to Director Parul Bhandari will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare technology sector to incentivize long-term performance and align executive interests with shareholders. The structure of this award, with a delayed vesting schedule, is typical for fostering sustained commitment.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity award aligns director interests with long-term shareholder value, potentially leading to better strategic decisions. The dilution from new shares is minimal given the standard nature of such awards.
• Employees: The existence of the 2025 Omnibus Incentive Plan suggests a broader framework for employee and executive compensation, which can impact morale and retention.
• Management: The award is a form of compensation for the director's services.

Next Steps

• Director Parul Bhandari's restricted stock units will vest on the date of the Issuer's 2027 annual stockholder meeting.
• The company will continue to operate under its 2025 Omnibus Incentive Plan.

Key Dates

Keywords

NRC Health, Form 4, SEC Filing, Equity Award, Restricted Stock Units, Director Compensation, Omnibus Incentive Plan, Beneficial Ownership